Education
About Us
Working with TipRanks
Follow Us
Impedimed Limited (IPDQF)
OTHER OTC:IPDQF
Total Valuation
Impedimed Limited has a market cap or net worth of $44.18M. The enterprise value is $122.17M.
Market Cap$44.18M
Enterprise Value$122.17M
Share Statistics
Impedimed Limited has 2,027,486,200 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,027,486,200
Owned by Insiders0.50%
Owned by Institutions<0.01%
Financial Efficiency
Impedimed Limited’s return on equity (ROE) is -0.49 and return on invested capital (ROIC) is -42.61%.
Return on Equity (ROE)-0.49
Return on Assets (ROA)-0.42
Return on Invested Capital (ROIC)-42.61%
Return on Capital Employed (ROCE)-0.45
Revenue Per Employee124.33K
Profits Per Employee-238.43K
Employee Count83
Asset Turnover0.22
Inventory Turnover1.73
Valuation Ratios
The current PE Ratio of Impedimed Limited is -7.25. Impedimed Limited’s PEG ratio is 0.52.
PE Ratio-7.25
PS Ratio24.15
PB Ratio3.52
Price to Fair Value3.52
Price to FCF-6.87
Price to Operating Cash Flow-8.07
PEG Ratio0.52
Income Statement
In the last 12 months, Impedimed Limited had revenue of 10.32M and earned -19.79M in profits. Earnings per share was -0.01.
Revenue10.32M
Gross Profit9.01M
Operating Income-19.04M
Pretax Income-20.73M
Net Income-19.79M
EBITDA-22.05M
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was -18.29M and capital expenditures -1.43M, giving a free cash flow of -19.72M billion.
Operating Cash Flow-18.29M
Free Cash Flow-19.72M
Free Cash Flow per Share>-0.01
Dividends & Yields
Impedimed Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.46
52-Week Price Change-66.67%
50-Day Moving Average0.03
200-Day Moving Average0.04
Relative Strength Index (RSI)22.62
Average Volume (3m)4.00K
Important Dates
Impedimed Limited upcoming earnings date is Aug 28, 2024, TBA Not Confirmed.
Last Earnings DateFeb 26, 2024
Next Earnings DateAug 28, 2024
Ex-Dividend Date―
Financial Position
Impedimed Limited as a current ratio of 6.33, with Debt / Equity ratio of 3.24%
Current Ratio6.33
Quick Ratio6.16
Debt to Market Cap0.00
Net Debt to EBITDA1.07
Interest Coverage Ratio-204.69
Taxes
In the past 12 months, Impedimed Limited has paid -935.00K in taxes.
Income Tax-935.00K
Effective Tax Rate0.05
Enterprise Valuation
Impedimed Limited EV to EBITDA ratio is -5.44, with an EV/FCF ratio of -5.75.
EV to Sales11.63
EV to EBITDA-5.44
EV to Free Cash Flow-5.75
EV to Operating Cash Flow-6.75
Balance Sheet
Impedimed Limited has $17.69M in cash and marketable securities with AU$1.05M in debt, giving a net cash position of -$16.65M billion.
Cash & Marketable Securities$17.69M
Total DebtAU$1.05M
Net Cash-$16.65M
Net Cash Per Share>-$0.01
Tangible Book Value Per Share$0.01
Margins
Gross margin is 87.88%, with operating margin of -184.48%, and net profit margin of -191.78%.
Gross Margin87.88%
Operating Margin-184.48%
Pretax Margin-200.84%
Net Profit Margin-191.78%
EBITDA Margin-213.69%
EBIT Margin-235.53%
Analyst Forecast
The average price target for Impedimed Limited is $0.11, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$0.11
Price Target Upside450.00% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast―
EPS Growth Forecast―